Archive


Category: ~$1B

  • Eli Lilly to Acquire Protomer Technologies for ~$1B

    Shots: Eli Lilly to acquire Protomer Technologies for ~$1B, with the achievement of future development and commercial milestones Earlier, Lilly led an equity investment in Protomer along with JDRF T1D fund that provides Lilly with 14% ownership of promotor and is currently acquiring the remaining shares of Protomer beyond the initial investment The acquisition will […]

  • Cardinal Health to Divest its Cordis Business to Hellman & Friedman for $1B

    Shots: Cardinal Health signed an agreement to divest its Cordis medical device business to H&F for ~ $1B including liabilities and working capital accounts. The transaction is expected to close in the H1’ 22 Following the completion of the agreement, H&F will assume most of the Cordis assets and liabilities while Cardinal Health will retain […]

  • Genentech Signs ~$1B Pact with Ribometrix to Develop RNA-Targeted Small Molecule Therapies

    Shots: Ribometrix to receive $25M up front, ~$1B+ as milestones along with royalties on sales of therapies emerges from the collaboration The companies collaborated on the discovery & preclinical development of programs. Genentech will lead further development and commercialization and will have exclusive rights to several predefined targets including an exclusive global license for the […]